Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biora Therapeutics, Inc. - Common Stock (NQ: PROG )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biora Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
The Long-Term Story Still Holds True for Volatile Progenity Stock
Biotech play PROG stock will likely continue to move wildly, until it makes breakthroughs with its promising pipeline. 
Via InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-... 
Via Benzinga
Progenity Stock Needs to Fall Further to Become a Viable Investment
The money has already been made on PROG stock and there is little incentive to invest in this one beyond the potential of a short squeeze. 
Via InvestorPlace
Progenity Stock Looks Poised to Become a Big Winner
Progenity's products are well-positioned to save a great deal of time and money, while the valuation of PROG stock is reasonable. 
Via InvestorPlace
60 Biggest Movers From Yesterday
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore... 
Via Benzinga
Capital Raises Add Confidence to Fast-Moving Biotech Progenity
Unique delivery of GI-disease treatments - along with multiple liquidity infusions - should help to ease the concerns of PROG stock holders. 
Via InvestorPlace
50 Biggest Movers From Yesterday
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial... 
Via Benzinga
7 Penny Stocks to Sell Before Year End
Before you close the books on 2021, if you hold a position in any of these seven penny stocks to sell, make sure to make your exit. Camber Energy (NYSEAMERICAN:CEI) Clover Health (NASDAQ:CLOV) Express... 
Via InvestorPlace
21 Stocks Moving In Tuesday's Pre-Market Session
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 201% to $4.00 in pre-market trading. The company filed proxy statement for annual meeting after the market close on... 
Via Benzinga
5 Short Squeeze Candidates For The Week: AGC SPAC Rejoins, Digital Ally, Tattooed Chef Join Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) or AMC Entertainment Holdings Inc (NYSE: AMC). A... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... 
Via Benzinga
Progenity Has Too Many Problems, Not Enough Money?
One of the many recent IPOs since the Covid-19 pandemic, PROG stock has encountered numerous setbacks to be a comfortable ride. With their partnership with Avero Diagnotics, management is currently... 
Via InvestorPlace
Exposures COVID-19
54 Biggest Movers From Yesterday
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company... 
Via Benzinga
Exposures Product Safety
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Roche's Spark Subsidiary Reports Positive Phase 1/2 Data For Hemophilia... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Sono Group N.V. (NASDAQ: SEV) rose 33% to $50.80 in pre-market trading. Sono Group shares climbed 155% on Wednesday after the company priced its IPO at $15 per share.... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RA... 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Nov. 17
Top Tickers: AAPL, TSLA, LCID, AMD, PROG, RIVN, PYPL, QCOM, NVDA, RBLX, PFE, AMC, FB, AMZN, F, ROKU, GM, V, BA, MSFT. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10... 
Via Benzinga
80 Biggest Movers From Yesterday
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... 
Via Benzinga
4 New Patents Add to Progenity’s Appeal
PROG stock has had its fair share of ups and downs. With a major executive-level change, however, Progenity looked poised for progress. 
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Why Progenity Stock Is Up More Than 34% Tuesday
Shares of the biotech stock rose more than $1.50 per share Tuesday morning. 
Via The Motley Fool
Most Active Equity Options For Midday - Tuesday, Nov. 16
Top Tickers: TSLA, LCID, AAPL, AMD, PROG, F, PTON, RBLX, UBER, WMT, AMC, FB, NIO, MSFT, BA, ATVI, INTC, NVDA, MARA, PFE. 
Via Talk Markets
PROG Stock Alert: What Is Going on With Progenity Today?
Popular short play Progenity is enjoying a good week. PROG stock is gaining as investors continue to bet against short sellers. 
Via InvestorPlace
53 Stocks Moving In Tuesday's Mid-Day Session
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to... 
Via Benzinga
With Progenity, What Is Pumped Will Be Dumped
PROG stock is among the raft of penny stock short squeezes on Reddit. Don't be left HODLing when the music stops. 
Via InvestorPlace
Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations
Following the market opening Tuesday, the Dow traded up 0.40% to 36,231.05 while the NASDAQ rose 0.20% to 15,885.76. The S&P also rose, gaining 0.31% to 4,697.11. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback